Helen Campbell

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. pmc Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
    Helen Campbell
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
    Clin Vaccine Immunol 17:840-7. 2010
  2. pmc The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient survey
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, England
    PLoS ONE 9:e111807. 2014
  3. doi Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines
    Shamez N Ladhani
    Health Protection Agency Colindale, Immunisation Department, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Vaccine 30:3710-6. 2012
  4. doi Effectiveness of maternal pertussis vaccination in England: an observational study
    Gayatri Amirthalingam
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, UK
    Lancet 384:1521-8. 2014
  5. doi Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®))
    Shamez N Ladhani
    Immunisation Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom Paediatric Infectious Diseases Research Group, St George s University of London, Cranmer Terrace, London SW17 0RE, United Kingdom Electronic address
    J Infect 69:470-80. 2014
  6. pmc The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, England
    PLoS ONE 8:e76180. 2013
  7. doi Meningococcal C conjugate vaccine: the experience in England and Wales
    Helen Campbell
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
    Vaccine 27:B20-9. 2009

Detail Information

Publications7

  1. pmc Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
    Helen Campbell
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
    Clin Vaccine Immunol 17:840-7. 2010
    ..Modeling suggested that protection against carriage persists for at least 3 years and predicted the stabilization of serogroup C disease at low levels (fewer than 50 cases per year) up to 2015-2016...
  2. pmc The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient survey
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, England
    PLoS ONE 9:e111807. 2014
    ..This provided an opportunity to estimate the disease burden in those aged 5 years and over. As pertussis is likely to be under reported both laboratory-confirmed and non-confirmed cases were included...
  3. doi Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines
    Shamez N Ladhani
    Health Protection Agency Colindale, Immunisation Department, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Vaccine 30:3710-6. 2012
    ....
  4. doi Effectiveness of maternal pertussis vaccination in England: an observational study
    Gayatri Amirthalingam
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, UK
    Lancet 384:1521-8. 2014
    ..We aimed to assess the vaccine effectiveness and the overall effect of the vaccine programme in preventing pertussis in infants...
  5. doi Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®))
    Shamez N Ladhani
    Immunisation Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom Paediatric Infectious Diseases Research Group, St George s University of London, Cranmer Terrace, London SW17 0RE, United Kingdom Electronic address
    J Infect 69:470-80. 2014
    ..To assess the potential use of a protein-based meningococcal group B (MenB) vaccine (Bexsero(®)) in addition to antibiotic chemoprophylaxis for preventing secondary cases...
  6. pmc The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, England
    PLoS ONE 8:e76180. 2013
    ..The least contact was between adolescents and infants. Thus the impact of adolescent (pertussis) vaccination on infants would likely be limited, unless it reduces transmission to other age groups whose contact with infants is greater...
  7. doi Meningococcal C conjugate vaccine: the experience in England and Wales
    Helen Campbell
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
    Vaccine 27:B20-9. 2009
    ..The MCC immunization programme has been extremely successful in controlling serogroup C disease and continues to be evaluated. The aim of this paper is to review the experiences in England and Wales over the past 9 years...